Intravenous ketorolac in the emergency department management of sickle cell pain and predictors of its effectiveness. | Profiles RNS

RCMI Coordinating Center (RCMI CC)

Intravenous ketorolac in the emergency department management of sickle cell pain and predictors of its effectiveness.

Beiter JL, Simon HK, Chambliss CR, Adamkiewicz T, Sullivan K. Intravenous ketorolac in the emergency department management of sickle cell pain and predictors of its effectiveness. Arch Pediatr Adolesc Med. 2001 Apr; 155(4):496-500.

View in: PubMed

authors with profiles

Thomas Adamkiewicz

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support